Molecular mechanisms of endometrial progesterone resistance
子宫内膜黄体酮抵抗的分子机制
基本信息
- 批准号:10618181
- 负责人:
- 金额:$ 51.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AblationAnimal ModelBiological AvailabilityBiological ModelsCXCL9 geneCenters for Disease Control and Prevention (U.S.)CouplesDefectDevelopmentDiagnosisDiseaseERBB2 geneEndometrialEndometrial Stromal CellEndometriumEpitheliumEstrogensEtiologyFemaleFemale infertilityFunctional disorderGenesGenetic ModelsGenetically Engineered MouseHumanImaging TechniquesImpairmentInfertilityKnock-outMediatingMediatorMitogensMolecularMorphologyMusPhenotypePregnancyProgesteroneProgesterone ReceptorsProliferatingProto-OncogenesRegulationResistanceRoleSignal PathwaySignal TransductionSpontaneous abortionSpousesTestingTissuesUterusWomanWomen&aposs HealthWorkage groupagedbiomedical imagingcostearly pregnancy lossendometriosis-related infertilityexperimental studyfailure Implantationhormone regulationimplantationinfertility treatmentmolecular dynamicsmouse modelmyometriumnatural Blastocyst Implantationoverexpressionpopulation basedpregnancy failurepregnantreproductivereproductive tractresponsesuccesstrying to conceiveuterine receptivity
项目摘要
Project Summary
The Centers for Disease Control and Prevention has estimated that there are approximately 6.1 million infertile
couples with a female spouse aged 15-44 in the U.S., which is about 6.7% of the domestic married couple
population base for that age group. Miscarriage before 20 weeks also occurs in about 15% of known
pregnancies, and over 75% of failed pregnancies involve implantation defects. To solve these problems, we
must understand the mechanisms of uterine receptivity and implantation to develop better treatments that may
be currently out of reach. The endometrium's epithelial and stromal compartments undergo dynamic molecular
and morphological changes to prepare for implantation and development. Endometrial P4 resistance implies a
decreased responsiveness of target tissue to bioavailable P4, and such an impaired P4 response is seen in the
endometrium of women with non-receptive endometrium. However, exactly how P4 signaling becomes
defective in a non-receptive endometrium is still unclear. MIG-6 acts as a key P4 signaling mediator to inhibit
E2-mediated epithelial proliferation in the endometrium of the human and mouse. We hypothesize that Mig-6
loss causes endometrial P4 resistance by ErbB2 overexpression in the endometrium and by dysregulating P4
signaling in endometrial stromal cells. In this proposal, our objective is to determine how MIG-6 functions in the
uterus and how it is dysregulated in endometrial P4 resistance and infertility. Our Specific Aims are directed at
understanding: 1) the pathophysiological role of MIG-6 loss in implantation failure; and 2) the effect of Erbb2
ablation on female infertility with Mig-6 deficiency. Using our mouse models and biomedical imaging
techniques, we will determine the role of Mig-6 loss in implantation failure and test Erbb2 targeting to treat
endometrial P4 resistance and restore implantation. Our results will enhance our understanding of reproductive
pathophysiology as well as enable the development of more effective strategies for the diagnosis and
treatment of infertility.
项目概要
美国疾病控制与预防中心估计,大约有 610 万人不孕不育。
美国有15-44岁女性配偶的夫妇,约占国内已婚夫妇的6.7%
该年龄组的人口基数。大约 15% 的已知女性也会在 20 周前流产
妊娠失败,超过 75% 的妊娠失败涉及着床缺陷。为了解决这些问题,我们
必须了解子宫容受性和着床的机制,以开发更好的治疗方法
目前遥不可及。子宫内膜的上皮和间质室经历动态分子变化
和形态变化,为植入和发育做准备。子宫内膜 P4 抵抗意味着
靶组织对生物可利用的 P4 的反应性降低,这种受损的 P4 反应见于
具有非接受性子宫内膜的女性的子宫内膜。然而,P4 信号到底如何变成
非容受性子宫内膜有缺陷尚不清楚。 MIG-6 作为关键的 P4 信号传导介质来抑制
E2 介导的人类和小鼠子宫内膜上皮增殖。我们假设 Mig-6
子宫内膜中 ErbB2 过度表达和 P4 失调导致子宫内膜 P4 抵抗
子宫内膜基质细胞中的信号传导。在本提案中,我们的目标是确定 MIG-6 在
子宫及其在子宫内膜 P4 抵抗和不孕症中的失调。我们的具体目标是
理解:1)MIG-6缺失在着床失败中的病理生理学作用; 2)Erbb2的影响
消融治疗 Mig-6 缺乏症女性不孕症。使用我们的小鼠模型和生物医学成像
技术,我们将确定 Mig-6 缺失在植入失败中的作用,并测试 Erbb2 靶向治疗
子宫内膜P4抵抗并恢复着床。我们的结果将增强我们对生殖的理解
病理生理学以及能够制定更有效的诊断和策略策略
治疗不孕症。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
SIRT1 plays an important role in implantation and decidualization during mouse early pregnancy.
SIRT1在小鼠妊娠早期的植入和蜕膜化中发挥重要作用。
- DOI:
- 发表时间:2022-06-13
- 期刊:
- 影响因子:3.6
- 作者:Hwang, Yeon Jeong;Sung, Gi;Marquardt, Ryan;Young, Steven L;Lessey, Bruce A;Kim, Tae Hoon;Cheon, Yong;Jeong, Jae
- 通讯作者:Jeong, Jae
ARID1A and PGR proteins interact in the endometrium and reveal a positive correlation in endometriosis.
ARID1A 和 PGR 蛋白在子宫内膜中相互作用,揭示了子宫内膜异位症的正相关性。
- DOI:
- 发表时间:2021
- 期刊:
- 影响因子:3.1
- 作者:Kim, Hong Im;Kim, Tae Hoon;Yoo, Jung;Young, Steven L;Lessey, Bruce A;Ku, Bon Jeong;Jeong, Jae
- 通讯作者:Jeong, Jae
Endometrial Epithelial ARID1A Is Required for Uterine Immune Homeostasis during Early Pregnancy.
子宫内膜上皮 ARID1A 是妊娠早期子宫免疫稳态所必需的。
- DOI:
- 发表时间:2022-05-28
- 期刊:
- 影响因子:5.6
- 作者:Marquardt, Ryan M;Ahn, Soo Hyun;Reske, Jake J;Chandler, Ronald L;Petroff, Margaret G;Kim, Tae Hoon;Jeong, Jae
- 通讯作者:Jeong, Jae
Role of SIRT1 and Progesterone Resistance in Normal and Abnormal Endometrium.
SIRT1 和孕酮抵抗在正常和异常子宫内膜中的作用。
- DOI:
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Kim, Tae Hoon;Young, Steven L;Sasaki, Tsutomu;Deaton, Jeffrey L;Schammel, David P;Palomino, Wilder Alberto;Jeong, Jae;Lessey, Bruce A
- 通讯作者:Lessey, Bruce A
Epigenetic Dysregulation in Endometriosis: Implications for Pathophysiology and Therapeutics.
子宫内膜异位症的表观遗传失调:对病理生理学和治疗学的影响。
- DOI:
- 发表时间:2023-11-09
- 期刊:
- 影响因子:20.3
- 作者:Marquardt, Ryan M;Tran, Dinh Nam;Lessey, Bruce A;Rahman, Md Saidur;Jeong, Jae
- 通讯作者:Jeong, Jae
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jae-Wook Jeong其他文献
Jae-Wook Jeong的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jae-Wook Jeong', 18)}}的其他基金
Epigenetic regulation of receptive endometrium
容受性子宫内膜的表观遗传调控
- 批准号:
10674101 - 财政年份:2022
- 资助金额:
$ 51.47万 - 项目类别:
The role of cholesterol biosynthesis in metastatic and recurrent endometrialcancer
胆固醇生物合成在转移性和复发性子宫内膜癌中的作用
- 批准号:
10560609 - 财政年份:2022
- 资助金额:
$ 51.47万 - 项目类别:
The role of cholesterol biosynthesis in metastatic and recurrent endometrialcancer
胆固醇生物合成在转移性和复发性子宫内膜癌中的作用
- 批准号:
10661912 - 财政年份:2022
- 资助金额:
$ 51.47万 - 项目类别:
Molecular mechanisms of endometrial progesterone resistance
子宫内膜黄体酮抵抗的分子机制
- 批准号:
10662676 - 财政年份:2022
- 资助金额:
$ 51.47万 - 项目类别:
Epigenetic regulation of receptive endometrium
容受性子宫内膜的表观遗传调控
- 批准号:
10551346 - 财政年份:2022
- 资助金额:
$ 51.47万 - 项目类别:
The role of cholesterol biosynthesis in metastatic and recurrent endometrial cancer
胆固醇生物合成在转移性和复发性子宫内膜癌中的作用
- 批准号:
10467152 - 财政年份:2022
- 资助金额:
$ 51.47万 - 项目类别:
Development of anti-inflammatory nanodrug for endometriosis treatment
开发治疗子宫内膜异位症的抗炎纳米药物
- 批准号:
10709492 - 财政年份:2022
- 资助金额:
$ 51.47万 - 项目类别:
Molecular mechanisms of endometrial progesterone resistance
子宫内膜黄体酮抵抗的分子机制
- 批准号:
10662676 - 财政年份:2022
- 资助金额:
$ 51.47万 - 项目类别:
SIRT1 as a Therapeutic Target in Endometriosis
SIRT1 作为子宫内膜异位症的治疗靶点
- 批准号:
10700024 - 财政年份:2021
- 资助金额:
$ 51.47万 - 项目类别:
SIRT1 as a Therapeutic Target in Endometriosis
SIRT1 作为子宫内膜异位症的治疗靶点
- 批准号:
10309093 - 财政年份:2021
- 资助金额:
$ 51.47万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
探索在急性呼吸窘迫综合征动物模型和患者长时间俯卧位通气过程中动态滴定呼气末正压的意义
- 批准号:82270081
- 批准年份:2022
- 资助金额:76 万元
- 项目类别:面上项目
雌激素抑制髓系白血病动物模型中粒细胞异常增生的机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于中医经典名方干预效应差异的非酒精性脂肪性肝病动物模型证候判别研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Preclinical assessment of a novel systemic drug candidate for osteoarthritic pain
治疗骨关节炎疼痛的新型全身候选药物的临床前评估
- 批准号:
10642544 - 财政年份:2023
- 资助金额:
$ 51.47万 - 项目类别:
Harnessing the Lysosome Machinery to Counter Metal Toxicity
利用溶酶体机制对抗金属毒性
- 批准号:
10689401 - 财政年份:2022
- 资助金额:
$ 51.47万 - 项目类别:
Development of a cell-penetrating beta-catenin antagonist peptide as a therapeutic candidate for Wnt-driven breast cancer
开发细胞穿透性 β-连环蛋白拮抗剂肽作为 Wnt 驱动乳腺癌的候选治疗药物
- 批准号:
10707593 - 财政年份:2021
- 资助金额:
$ 51.47万 - 项目类别:
Novel downstream effectors of protein kinase G in hypertensive disease
高血压疾病中蛋白激酶 G 的新型下游效应子
- 批准号:
10593096 - 财政年份:2021
- 资助金额:
$ 51.47万 - 项目类别:
Novel downstream effectors of protein kinase G in hypertensive disease
高血压疾病中蛋白激酶 G 的新型下游效应子
- 批准号:
10593096 - 财政年份:2021
- 资助金额:
$ 51.47万 - 项目类别: